These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


130 related items for PubMed ID: 16876404

  • 1. Morpholin-2-one derivatives as novel selective T-type Ca2+ channel blockers.
    Ku IW, Cho S, Doddareddy MR, Jang MS, Keum G, Lee JH, Chung BY, Kim Y, Rhim H, Kang SB.
    Bioorg Med Chem Lett; 2006 Oct 01; 16(19):5244-8. PubMed ID: 16876404
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and biological activity of 3,4-dihydroquinazolines for selective T-type Ca2+ channel blockers.
    Rhim H, Lee YS, Park SJ, Chung BY, Lee JY.
    Bioorg Med Chem Lett; 2005 Jan 17; 15(2):283-6. PubMed ID: 15603940
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and SAR studies of a novel series of T-type calcium channel blockers.
    Park SJ, Park SJ, Lee MJ, Rhim H, Kim Y, Lee JH, Chung BY, Lee JY.
    Bioorg Med Chem; 2006 May 15; 14(10):3502-11. PubMed ID: 16434203
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. 3D pharmacophore based virtual screening of T-type calcium channel blockers.
    Doddareddy MR, Choo H, Cho YS, Rhim H, Koh HY, Lee JH, Jeong SW, Pae AN.
    Bioorg Med Chem; 2007 Jan 15; 15(2):1091-105. PubMed ID: 17074493
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synthesis and biological evaluation of novel T-type Ca2+ channel blockers.
    Jung HK, Doddareddy MR, Cha JH, Rhim H, Cho YS, Koh HY, Jung BY, Pae AN.
    Bioorg Med Chem; 2004 Aug 01; 12(15):3965-70. PubMed ID: 15246072
    [Abstract] [Full Text] [Related]

  • 9. Lead discovery and optimization of T-type calcium channel blockers.
    Park JH, Choi JK, Lee E, Lee JK, Rhim H, Seo SH, Kim Y, Doddareddy MR, Pae AN, Kang J, Roh EJ.
    Bioorg Med Chem; 2007 Feb 01; 15(3):1409-19. PubMed ID: 17150365
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Synthesis and evaluation of alpha,alpha'-disubstituted phenylacetate derivatives for T-type calcium channel blockers.
    Lee HK, Lee YS, Roh EJ, Rhim H, Lee JY, Shin KJ.
    Bioorg Med Chem Lett; 2008 Aug 01; 18(15):4424-7. PubMed ID: 18625556
    [Abstract] [Full Text] [Related]

  • 13. Five different profiles of dihydropyridines in blocking T-type Ca(2+) channel subtypes (Ca(v)3.1 (alpha(1G)), Ca(v)3.2 (alpha(1H)), and Ca(v)3.3 (alpha(1I))) expressed in Xenopus oocytes.
    Furukawa T, Nukada T, Namiki Y, Miyashita Y, Hatsuno K, Ueno Y, Yamakawa T, Isshiki T.
    Eur J Pharmacol; 2009 Jun 24; 613(1-3):100-7. PubMed ID: 19401195
    [Abstract] [Full Text] [Related]

  • 14. Scaffold-based design and synthesis of potent N-type calcium channel blockers.
    Zamponi GW, Feng ZP, Zhang L, Pajouhesh H, Ding Y, Belardetti F, Pajouhesh H, Dolphin D, Mitscher LA, Snutch TP.
    Bioorg Med Chem Lett; 2009 Nov 15; 19(22):6467-72. PubMed ID: 19815411
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Discovery of potent T-type calcium channel blocker.
    Seo HN, Choi JY, Choe YJ, Kim Y, Rhim H, Lee SH, Kim J, Joo DJ, Lee JY.
    Bioorg Med Chem Lett; 2007 Nov 01; 17(21):5740-3. PubMed ID: 17869104
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and biological evaluation of oxazole derivatives as T-type calcium channel blockers.
    Lee JE, Koh HY, Seo SH, Baek YY, Rhim H, Cho YS, Choo H, Pae AN.
    Bioorg Med Chem Lett; 2010 Jul 15; 20(14):4219-22. PubMed ID: 20621730
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and SAR study of T-type calcium channel blockers. Part II.
    Choe YJ, Seo HN, Jung SY, Rhim H, Kim J, Choo DJ, Lee JY.
    Arch Pharm (Weinheim); 2008 Oct 15; 341(10):661-4. PubMed ID: 18816587
    [Abstract] [Full Text] [Related]

  • 19. C101, a novel 4-amino-piperidine derivative selectively blocks N-type calcium channels.
    Zhang S, Su R, Zhang C, Liu X, Li J, Zheng J.
    Eur J Pharmacol; 2008 Jun 10; 587(1-3):42-7. PubMed ID: 18468596
    [Abstract] [Full Text] [Related]

  • 20. Ca2+ channel subtypes and pharmacology in the kidney.
    Hayashi K, Wakino S, Sugano N, Ozawa Y, Homma K, Saruta T.
    Circ Res; 2007 Feb 16; 100(3):342-53. PubMed ID: 17307972
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.